Cell-Type-Specific, Ketohexokinase-Dependent Induction by Fructose of Lipogenic Gene Expression in Mouse Small Intestine.
chylomicron
epithelia
lipids
lipogenesis
liver
organoids
stem cells
sugars
Journal
The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243
Informations de publication
Date de publication:
01 07 2020
01 07 2020
Historique:
received:
01
11
2019
revised:
06
01
2020
accepted:
01
04
2020
pubmed:
10
5
2020
medline:
18
11
2020
entrez:
10
5
2020
Statut:
ppublish
Résumé
High intakes of fructose are associated with metabolic diseases, including hypertriglyceridemia and intestinal tumor growth. Although small intestinal epithelia consist of many different cell types, express lipogenic genes, and convert dietary fructose to fatty acids, there is no information on the identity of the cell type(s) mediating this conversion and on the effects of fructose on lipogenic gene expression. We hypothesized that fructose regulates the intestinal expression of genes involved in lipid and apolipoprotein synthesis, that regulation depends on the fructose transporter solute carrier family 2 member a5 [Slc2a5 (glucose transporter 5)] and on ketohexokinase (Khk), and that regulation occurs only in enterocytes. We compared lipogenic gene expression among different organs from wild-type adult male C57BL mice consuming a standard vivarium nonpurified diet. We then gavaged twice daily for 2.5 d fructose or glucose solutions (15%, 0.3 mL per mouse) into wild-type, Slc2a5-knockout (KO), and Khk-KO mice with free access to the nonpurified diet and determined expression of representative lipogenic genes. Finally, from mice fed the nonpurified diet, we made organoids highly enriched in enterocyte, goblet, Paneth, or stem cells and then incubated them overnight in 10 mM fructose or glucose. Most lipogenic genes were significantly expressed in the intestine relative to the kidney, liver, lung, and skeletal muscle. In vivo expression of Srebf1, Acaca, Fasn, Scd1, Dgat1, Gk, Apoa4, and Apob mRNA and of Scd1 protein increased (P < 0.05) by 3- to 20-fold in wild-type, but not in Slc2a5-KO and Khk-KO, mice gavaged with fructose. In vitro, Slc2a5- and Khk-dependent, fructose-induced increases, which ranged from 1.5- to 4-fold (P < 0.05), in mRNA concentrations of all these genes were observed only in organoids enriched in enterocytes. Fructose specifically stimulates expression of mouse small intestinal genes for lipid and apolipoprotein synthesis. Secretory and stem cells seem incapable of transport- and metabolism-dependent lipogenesis, occurring only in absorptive enterocytes.
Sections du résumé
BACKGROUND
High intakes of fructose are associated with metabolic diseases, including hypertriglyceridemia and intestinal tumor growth. Although small intestinal epithelia consist of many different cell types, express lipogenic genes, and convert dietary fructose to fatty acids, there is no information on the identity of the cell type(s) mediating this conversion and on the effects of fructose on lipogenic gene expression.
OBJECTIVES
We hypothesized that fructose regulates the intestinal expression of genes involved in lipid and apolipoprotein synthesis, that regulation depends on the fructose transporter solute carrier family 2 member a5 [Slc2a5 (glucose transporter 5)] and on ketohexokinase (Khk), and that regulation occurs only in enterocytes.
METHODS
We compared lipogenic gene expression among different organs from wild-type adult male C57BL mice consuming a standard vivarium nonpurified diet. We then gavaged twice daily for 2.5 d fructose or glucose solutions (15%, 0.3 mL per mouse) into wild-type, Slc2a5-knockout (KO), and Khk-KO mice with free access to the nonpurified diet and determined expression of representative lipogenic genes. Finally, from mice fed the nonpurified diet, we made organoids highly enriched in enterocyte, goblet, Paneth, or stem cells and then incubated them overnight in 10 mM fructose or glucose.
RESULTS
Most lipogenic genes were significantly expressed in the intestine relative to the kidney, liver, lung, and skeletal muscle. In vivo expression of Srebf1, Acaca, Fasn, Scd1, Dgat1, Gk, Apoa4, and Apob mRNA and of Scd1 protein increased (P < 0.05) by 3- to 20-fold in wild-type, but not in Slc2a5-KO and Khk-KO, mice gavaged with fructose. In vitro, Slc2a5- and Khk-dependent, fructose-induced increases, which ranged from 1.5- to 4-fold (P < 0.05), in mRNA concentrations of all these genes were observed only in organoids enriched in enterocytes.
CONCLUSIONS
Fructose specifically stimulates expression of mouse small intestinal genes for lipid and apolipoprotein synthesis. Secretory and stem cells seem incapable of transport- and metabolism-dependent lipogenesis, occurring only in absorptive enterocytes.
Identifiants
pubmed: 32386219
pii: S0022-3166(22)02243-X
doi: 10.1093/jn/nxaa113
pmc: PMC7330472
doi:
Substances chimiques
Fructose
30237-26-4
Fructokinases
EC 2.7.1.-
ketohexokinase
EC 2.7.1.3
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1722-1730Subventions
Organisme : NCCIH NIH HHS
ID : R01 AT010243
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK102934
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK119198
Pays : United States
Informations de copyright
Copyright © The Author(s) on behalf of the American Society for Nutrition 2020.
Références
Am J Physiol Gastrointest Liver Physiol. 2015 Nov 1;309(9):G779-90
pubmed: 26316589
Diabetes. 2005 Aug;54(8):2328-35
pubmed: 16046298
Am J Clin Nutr. 2017 Aug;106(2):506-518
pubmed: 28592611
Nutrients. 2017 Apr 01;9(4):
pubmed: 28368310
J Biol Chem. 2002 Aug 30;277(35):31646-55
pubmed: 12070142
Am J Physiol Endocrinol Metab. 2018 Sep 1;315(3):E386-E393
pubmed: 29870677
Biochem Biophys Res Commun. 2009 Dec 11;390(2):285-9
pubmed: 19799862
Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E685-94
pubmed: 20823452
J Clin Invest. 2017 Nov 1;127(11):4059-4074
pubmed: 28972537
J Lipid Res. 2015 May;56(5):945-62
pubmed: 25387865
Obesity (Silver Spring). 2016 Mar;24(3):589-96
pubmed: 26916239
J Lipid Res. 2015 Mar;56(3):489-501
pubmed: 25231105
BMC Biol. 2018 Feb 01;16(1):19
pubmed: 29391007
J Lipid Res. 2014 Mar;55(3):561-72
pubmed: 24371263
Cell Metab. 2018 Feb 6;27(2):351-361.e3
pubmed: 29414685
Nat Commun. 2013;4:2434
pubmed: 24022321
Nutrients. 2014 Jul 15;6(7):2632-49
pubmed: 25029210
J Biol Chem. 2004 Jun 11;279(24):25164-71
pubmed: 15066988
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4320-5
pubmed: 22371574
Trends Endocrinol Metab. 2011 Feb;22(2):60-5
pubmed: 21067942
Arterioscler Thromb Vasc Biol. 2013 May;33(5):1056-62
pubmed: 23471231
J Hepatol. 2018 May;68(5):1063-1075
pubmed: 29408694
J Lipid Res. 2009 Jul;50(7):1463-71
pubmed: 19305020
FASEB J. 2015 Sep;29(9):4046-58
pubmed: 26071406
PLoS One. 2014 Nov 17;9(11):e113058
pubmed: 25402228
Altern Med Rev. 2005 Dec;10(4):294-306
pubmed: 16366738
Am J Physiol Gastrointest Liver Physiol. 2005 Jun;288(6):G1310-20
pubmed: 15691865
J Clin Invest. 2013 Mar;123(3):1229-40
pubmed: 23376793
Am J Physiol Regul Integr Comp Physiol. 2015 Sep;309(5):R499-509
pubmed: 26084694
Nat Methods. 2014 Jan;11(1):106-12
pubmed: 24292484
Am J Physiol Gastrointest Liver Physiol. 2001 Jan;280(1):G113-20
pubmed: 11123204
Am J Respir Cell Mol Biol. 2004 Feb;30(2):174-83
pubmed: 12896875
PLoS One. 2013 Apr 18;8(4):e59763
pubmed: 23637738
Annu Rev Nutr. 2018 Aug 21;38:41-67
pubmed: 29751733
Biochem Biophys Res Commun. 2016 Oct 28;479(4):643-648
pubmed: 27697525
J Physiol. 2013 Jan 15;591(2):401-14
pubmed: 23129794
Diabetes. 2013 Jul;62(7):2259-65
pubmed: 23674606
J Biol Chem. 2008 Oct 31;283(44):29802-11
pubmed: 18768481
Cell. 2013 Jan 17;152(1-2):25-38
pubmed: 23273993
Science. 2019 Mar 22;363(6433):1345-1349
pubmed: 30898933
Nutr Metab (Lond). 2005 Aug 09;2:18
pubmed: 16091142
Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G592-G605
pubmed: 28336548
Br J Nutr. 2014 Jun;111 Suppl 1:S8-15
pubmed: 24382171
Dig Dis Sci. 2016 May;61(5):1282-93
pubmed: 26856717
Lab Invest. 2015 Dec;95(12):1409-17
pubmed: 26367490
PLoS One. 2011;6(11):e26583
pubmed: 22096489